Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
EMBO Molecular Medicine|October 2, 2024
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear importAude Boulay, Emmanuel Quevarec, Isabelle Malet, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 28, 2020
Evolution of viral quasispecies during SARS-CoV-2 infectionAude Jary, Valentin Leducq, Isabelle Malet, et al.Antiviral Research|December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutationsSlim Fourati, Isabelle Malet, Carolin A Guenzel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare WorkersStéphane Marot, Isabelle Malet, Valentin Leducq, et al.Nature Communications|February 9, 2021
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workersStéphane Marot, Isabelle Malet, Valentin Leducq, et al.Acta Dermato-Venereologica|July 4, 2020
Surveillance of Antibiotic Resistance Genes in Treponema Pallidum Subspecies Pallidum from Patients with Early Syphilis in FranceAdrien Sanchez, Constance Mayslich, Isabelle Malet, et al.Antiviral Therapy|March 27, 2009
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypesAlmoustapha-Issiaka Maïga, Isabelle Malet, Cathia Soulie, et al.The Journal of Antimicrobial Chemotherapy|January 27, 2018
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistanceIsabelle Malet, Francesca A Ambrosio, Frédéric Subra, et al.The Journal of Antimicrobial Chemotherapy|September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtypeIsabelle Malet, Slim Fourati, Charlotte Charpentier, et al.The Journal of Antimicrobial Chemotherapy|September 7, 2010
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitorsFrancesca Ceccherini-Silberstein, Isabelle Malet, Lavinia Fabeni, et al.Pageof 6